2007 Fiscal Year Final Research Report Summary
Generation of transplantable hematopoietic stem cells based from human embryonic stem cells
| Project/Area Number |
17390297
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Pediatrics
|
|---|
| Research Institution | The University of Tokyo |
|---|
Principal Investigator |
TSUJI Kohichiro The University of Tokyo, The Institute of Medical Science, Associate Professor (50179991)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
EBIHARA Yasuhiro The Institute of Medical Science, 医科学研究所, Assistant Professor (40302608)
|
|---|
| Project Period (FY) |
2005 – 2007
|
| Keywords | human embrvonic stem (ES) cells / hematopoietic stem cells / hematopoietic stem cell transplantation / hematopoietic progenitor cells / fetal hematoppiesis / fatal liver / stroma / transfusion |
|---|
| Research Abstract |
We proposed a novel method for the efficient production of hematopoietic progenitors from human embryonic stem cells (hESC) by co-culturing with stromal cells derived from murine fetal liver, in which embryonic hematopoiesis drastically expands at midgestation. In the co-culture, various hematopoietic progenitors were generated, and this hematopoietic activity was concentrated in cobblestone-like cells derived from differentiated hESC. The cobblestone-like cells mostly expressed CD34 and retained an endothelial potential. They also contained hematopoietic colony-forming cells, especially erythroid and multilineage colony-forming cells at high frequency. The multipotential hematopoietic progenitors abundant among the cobblestone-like cells produced almost all types of mature blood cells, including adult-type b globin-expressing erythrocytes and tryptase/chymase double-positive mast cells. They showed neither immature properties of ESC nor the potential to differentiate into endoderm and ectoderm at a clonal level. The developed co-culture system of hESC can provide a novel source for hematopoietic and blood cells applicable to cellular therapies and drug screenings.
|
Research Products
(58 results)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Patent(Industrial Property Rights)] 工業所有権2005
Inventor(s)
Kohichiro Tsuji, Feng Ma
Industrial Property Rights Holder
Kohichiro Tsuji, Fend Ma
Industrial Property Number
米国プロビシュアル出願(60/728,665)
Filing Date
2005-10-19
Description
「研究成果報告書概要(和文)」より
Overseas
